PlainRecalls
FDA Drug Moderate Class II Terminated

Bivalirudin for Injection 250 mg, 10 Single-Dose Vials, Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited Ahmedabad-382 210, India, NDC 16729-275-67.

Reported: July 19, 2023 Initiated: July 3, 2023 #D-0918-2023

Product Description

Bivalirudin for Injection 250 mg, 10 Single-Dose Vials, Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited Ahmedabad-382 210, India, NDC 16729-275-67.

Reason for Recall

Presence of Particulate Matter: Particulate matter identified as fiber.

Details

Recalling Firm
Accord Healthcare, Inc.
Units Affected
1680 vials
Distribution
Nationwide within the United States
Location
Durham, NC

Frequently Asked Questions

What product was recalled?
Bivalirudin for Injection 250 mg, 10 Single-Dose Vials, Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited Ahmedabad-382 210, India, NDC 16729-275-67.. Recalled by Accord Healthcare, Inc.. Units affected: 1680 vials.
Why was this product recalled?
Presence of Particulate Matter: Particulate matter identified as fiber.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 19, 2023. Severity: Moderate. Recall number: D-0918-2023.